HKD 0.38
(-1.32%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 59.7 Million CNY | -1.14% |
2022 | 63.41 Million CNY | 5.69% |
2021 | 60 Million CNY | 43.08% |
2020 | 41.93 Million CNY | 11.21% |
2019 | 37.7 Million CNY | 4.41% |
2018 | 36.06 Million CNY | 8.46% |
2017 | 33.27 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q4 | 14.65 Million CNY | 16.14% |
2023 Q3 | 12.61 Million CNY | 5.7% |
2023 Q1 | 5.96 Million CNY | -54.67% |
2023 Q2 | 11.93 Million CNY | 100.17% |
2023 FY | - CNY | -1.14% |
2022 Q2 | 13.73 Million CNY | 69.97% |
2022 FY | - CNY | 5.69% |
2022 Q4 | 13.15 Million CNY | 4.18% |
2022 Q3 | 12.63 Million CNY | -8.03% |
2022 Q1 | 8.07 Million CNY | -38.98% |
2021 FY | - CNY | 43.08% |
2021 Q4 | 13.24 Million CNY | -2.58% |
2021 Q3 | 13.59 Million CNY | 9.6% |
2021 Q2 | 12.4 Million CNY | 40.44% |
2021 Q1 | 8.83 Million CNY | -26.46% |
2020 FY | - CNY | 11.21% |
2020 Q4 | 12 Million CNY | 101.36% |
2020 Q3 | 5.96 Million CNY | -34.64% |
2020 Q2 | 9.12 Million CNY | 61.01% |
2020 Q1 | 5.66 Million CNY | -35.17% |
2019 Q2 | 7.33 Million CNY | 6.48% |
2019 FY | - CNY | 4.41% |
2019 Q4 | 8.74 Million CNY | -7.46% |
2019 Q1 | 6.88 Million CNY | 0.0% |
2019 Q3 | 9.44 Million CNY | 28.85% |
2018 FY | - CNY | 8.46% |
2017 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Starlite Holdings Limited | 71.42 Million HKD | 16.421% |
Litu Holdings Limited | 1.21 Million HKD | -4825.743% |
Touyun Biotech Group Limited | -228.56 Million HKD | 126.119% |
Champion Alliance International Holdings Limited | 35.89 Million HKD | -66.305% |
Huaxi Holdings Company Limited | -31.47 Million HKD | 289.65% |